Literature DB >> 24675145

Compression therapy versus surgery in the treatment of patients with varicose veins: A RCT.

H Sell1, P Vikatmaa1, A Albäck1, M Lepäntalo1, A Malmivaara2, O Mahmoud3, M Venermo4.   

Abstract

OBJECTIVE: Superficial venous reflux and varicose veins are common. The aim of this randomized controlled trial was to assess effectiveness of compression therapy compared with surgery for superficial venous reflux.
METHODS: 153 patients with CEAP class C2-C3 and superficial venous reflux were randomized to receive either conservative treatment (compression stockings) (n = 77) or surgery (n = 76). Clinical examination including duplex ultrasound (DUS) was performed at entry and 1 and 2 years after randomization (compression group) or surgery (surgery group). Venous Clinical Severity Score without compression stockings (VCSS-S), Venous Segmental Disease Score (VSDS), Venous Disability Score (VDS), and health-related quality of life (HRQoL) were assessed at entry and at the follow-ups. Data were analysed on an intention-to-treat basis and according to the actual treatment performed.
RESULTS: At 2 years, 70/76 patients in the surgery group and 11/77 patients in the compression group had been operated on. VCSS-S decreased from 4.6 to 3.5 in the compression group (p < .01) and from 4.8 to 0.6 in the surgery group (p < .001). VSDS decreased from 7.7 to 7.0 in the compression group and from 8.2 to 0.9 in the surgery group (p < .0001). HRQoL did not change in the compression group, but improved significantly in the surgery group.
CONCLUSION: The surgical elimination of non-complicated superficial venous reflux is an effective treatment when compared with providing compression stockings only.
Copyright © 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Compression therapy; Operative treatment; Superficial venous reflux; Varicose veins

Mesh:

Year:  2014        PMID: 24675145     DOI: 10.1016/j.ejvs.2014.02.015

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  5 in total

Review 1.  [Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC) : S2k guideline of the German Phlebology Society (DGP) in cooperation with the following professional associations: DDG, DGA, DGG, GDL, DGL, BVP. German version].

Authors:  E Rabe; E Földi; H Gerlach; M Jünger; G Lulay; A Miller; K Protz; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; F Pannier
Journal:  Hautarzt       Date:  2021-02       Impact factor: 0.751

Review 2.  Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement.

Authors:  Eberhard Rabe; Hugo Partsch; Juerg Hafner; Christopher Lattimer; Giovanni Mosti; Martino Neumann; Tomasz Urbanek; Monika Huebner; Sylvain Gaillard; Patrick Carpentier
Journal:  Phlebology       Date:  2017-02-22       Impact factor: 1.740

3.  Compliance with NICE guidelines when commissioning varicose vein procedures.

Authors:  D Carradice; J Forsyth; A Mohammed; C Leung; L Hitchman; A E Harwood; T Wallace; G E Smith; B Campbell; I Chetter
Journal:  BJS Open       Date:  2018-08-29

4.  Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins.

Authors:  M Venermo; J Saarinen; E Eskelinen; S Vähäaho; E Saarinen; M Railo; I Uurto; J Salenius; A Albäck
Journal:  Br J Surg       Date:  2016-08-26       Impact factor: 6.939

Review 5.  Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC) : S2k guideline of the German Phlebology Society (DGP) in cooperation with the following professional associations: DDG, DGA, DGG, GDL, DGL, BVP.

Authors:  E Rabe; E Földi; H Gerlach; M Jünger; G Lulay; A Miller; K Protz; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; F Pannier
Journal:  Hautarzt       Date:  2021-01-01       Impact factor: 0.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.